awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33404543-15797EC7-E0D6-43E1-8B5B-E77BA9FE87BC
Q33404543-15797EC7-E0D6-43E1-8B5B-E77BA9FE87BC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33404543-15797EC7-E0D6-43E1-8B5B-E77BA9FE87BC
Phase Ib trial of the oral angiogenesis inhibitor pazopanib administered concurrently with pemetrexed in patients with advanced solid tumors.
P2860
Q33404543-15797EC7-E0D6-43E1-8B5B-E77BA9FE87BC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33404543-15797EC7-E0D6-43E1-8B5B-E77BA9FE87BC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
64fd4c0592364929bbb8bf64a80ab2051c0c6f6e
P2860
Phase II study of pemetrexed and carboplatin plus bevacizumab with maintenance pemetrexed and bevacizumab as first-line therapy for nonsquamous non-small-cell lung cancer.